WP
RDY icon

WealthShield Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

WealthShield Partners’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-165
Closed -$2K – 1068
2021
Q1 		$2K Buy
+165
New +$2.12K ﹤0.01% 1072

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

WealthShield Partners's RDY Position: Q2 2021 in Review

WealthShield Partners sold out of Dr. Reddy's Laboratories (RDY) in Q2 2021, closing a stake of 165 shares — an estimated $2K sold.

WealthShield Partners first reported a position in RDY in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 161 funds tracked by Wall St. Rank hold RDY as of Q2 2021.

  • WealthShield Partners reported no remaining Dr. Reddy's Laboratories position as of Q2 2021 after selling out during the quarter.
  • WealthShield Partners sold 165 Dr. Reddy's Laboratories shares in Q2 2021, an estimated $2K.
  • WealthShield Partners first reported a position in Dr. Reddy's Laboratories in Q1 2021 and held it in 1 quarter.
  • WealthShield Partners's Dr. Reddy's Laboratories position peaked at $2K in Q1 2021.
  • 161 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2021.

Based on WealthShield Partners's 13F filing for Q2 2021, filed 6 Aug 2021.